Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lierkang Oral Liquid
- Development stage
- Unknown
- Lead developer
- Xian KeliKang Pharmaceutical Technology
- Administration
- Oral
01
Overview
**Lierkang Oral Liquid** is an approved oral liquid traditional medicine product associated with XianShi Pharmaceutical Group and listed among the company's commercial products. Publicly available source material identifies the product name, dosage form, route of administration, and company association, but does not disclose the active ingredients, precise indication, pharmacologic target, or mechanism of action. Based on the available information, it is best characterized as a marketed traditional medicine oral liquid formulation manufactured and/or commercialized by XianShi Pharmaceutical Group.
- Brand names
- Lierkang Oral Liquid
- Other names
- 利儿康口服液
Beyond the preview
Go deeper on Lierkang Oral Liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lierkang Oral Liquid.